Your browser doesn't support javascript.
loading
Lost Therapeutic Benefit of Delayed Low-Density Lipoprotein Cholesterol Control in Statin-Treated Patients and Cost-Effectiveness Analysis of Lipid-Lowering Intensification.
Marquina, Clara; Morton, Jedidiah; Zomer, Ella; Talic, Stella; Lybrand, Sean; Thomson, David; Liew, Danny; Ademi, Zanfina.
Afiliação
  • Marquina C; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia. Electronic address: clara.marquina@monash.edu.
  • Morton J; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
  • Zomer E; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Talic S; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Lybrand S; Amgen Europe GmbH, Rotkreuz ZG, Switzerland.
  • Thomson D; Amgen Australia Pty Ltd, Sydney, NSW, Australia.
  • Liew D; Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia.
  • Ademi Z; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia. Electronic address: zanfina.ademi@monash.edu.
Value Health ; 26(4): 498-507, 2023 04.
Article em En | MEDLINE | ID: mdl-36442832

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases Tipo de estudo: Clinical_trials / Health_economic_evaluation Limite: Adult / Humans País como assunto: Oceania Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases Tipo de estudo: Clinical_trials / Health_economic_evaluation Limite: Adult / Humans País como assunto: Oceania Idioma: En Ano de publicação: 2023 Tipo de documento: Article